Newsbenzinga
MediWound Says DSMB Recommends Phase III VALUE Study Of EscharEx Continues Without Modification, No Safety Concerns Identified
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Comments —
Loading comments…